Over the years, medicinal science has seen tremendous growth due to the incorporation of technology. Better methods of treating common ailments have been incorporated into the field of medicine, and discoveries have been made with regards to the invention of a cure for previously incurable malaises. All these developments have been achieved through the quest of medical research institutions to promote better livelihoods.
Among the widely acclaimed personalities in this years’ Forbes Midas list was one Mr.Jim Tananbaum, who is currently in charge of Foresite Capital as the C.E.O. Mr. Jim is known as a modern healthcare investor who does more than is expected of him in coming up with prestigious healthcare firms that reap huge dividends due to the improvement of sales and minimizing operational costs.
Bloomberg reveals that Mr. Tananbaum has a vast wealth of experience totaling to more than 25 years. His experience has made institutions like GelTex, Theravance, and Prospect Ventures make huge sales and hence become competitive institutions in the global market. At Foresite, he has come up with ingenious investment techniques that have proved to be helpful in creating capital for running enterprises attached to Foresite Capital.
Jim Tananbaum’s educational background is well established, thereby, enabling him to understand precisely how the global market operates. He graduated from Yale University with degrees in BS/BSEE. He furthered his education by enrolling to Harvard to pursue his M.B.A and Massachusetts Institute of Technology for his Master in Science program. He has supervised investments in massive health franchises such as Ameri group, and, Jazz Pharmaceuticals. These ventures have made him be assigned over sight tasks in the advisory committee boards of the Massachusetts Institute of Technology and the Yale School of Engineering.
Over the last five years, he has injected his prowess in Intercia Therapeutics and Puma Biotechnology, hence enabling them to do well in the global market scope. Since he was elected to be a C.E.O of NASDAQ, the company has seen tremendous growth by making sales of above $2 billion.
In the contemporary world where most of the human population is struggling with health lifestyle diseases and other non-communicable ailments, Mr. Jim Tananbaum has been an observer and he has made critical steps towards ensuring that quality healthcare can be availed to all.